<DOC>
	<DOCNO>NCT01597219</DOCNO>
	<brief_summary>This trial investigate stem cell transplant partially mismatch donor patient blood bone marrow cancer . The trial test two kind transplant - full intensity transplant use high dose radiotherapy chemotherapy , reduce intensity transplant low dos chemotherapy radiotherapy . Patients enter treatment pathway appropriate level health fitness</brief_summary>
	<brief_title>Trial Haploidentical Stem Cell Transplantation Haematological Cancers</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<mesh_term>Pancytopenia</mesh_term>
	<mesh_term>Hemoglobinuria , Paroxysmal</mesh_term>
	<mesh_term>Hematologic Neoplasms</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<criteria>Patient Inclusion Criteria 1 . Eligible allogeneic transplant line current BSBMT indication transplant criterion ( http : //bsbmt.org/indicationstable/ ) accept Commissioners 2 . Age 1670 3 . Adequate physical function Cardiac : LVEF rest ≥45 % , shorten fraction ≥25 % Hepatic : Bilirubin ≤35mmol/l ; AST/ALT alkaline phosphatase &lt; 5 x ULN Renal : Serum creatinine within normal range age , serum creatinine outside normal range age , creatinine clearance GFR &gt; 40ml/min/1.73m2 Pulmonary : FEV1 , FVC , DLCO ( diffusion capacity ) &gt; 50 % predict ( correct haemoglobin ) ; clinically unable perform pulmonary function test O2 saturation &gt; 92 % room air Performance status : Karnofsky score ≥60 % 4 . Donor available age ≥16 year 5 . Needs urgent transplant 10/10 HLA match sibling unrelated donor unavailable timely manner . An unrelated donor search require patient eligible clinical situation dictate urgent transplant . Clinical urgency define 68 week referral transplant centre low likelihood find match unrelated donor 6 . HLA type perform high resolution ( allelic ) HLAA , HLAB , HLACw , HLADRB1 HLADQB1 locus . A minimum match 5/10 require 7 . The donor recipient must identical determined high resolution type least one allele follow genetic locus : HLAA , HLAB , HLACw , HLADRB1 HLADQB1 . Fulfilment criterion sufficient evidence donor recipient share one HLA haplotype type additional family member require . 8 . Patient must receive cytotoxic chemotherapy within 3 month consent date ( measure start date recent cycle chemotherapy ) except patient aplastic anaemia , unless otherwise agree TMG ( see section 5.3.4 ) . The use monoclonal antibody therapy may consider cytotoxic chemotherapy , must agree TMG 9 . Written inform consent Donor Inclusion Criteria 1 . Donor must HLAhaploidentical first degree relative patient . Eligible donor include biological parent , sibling , child halfsiblings 2 . Age ≥16 year 3 . Donors must meet collection centre 's usual selection criterion relate allogeneic HPC donor Patient Exclusion Criteria 1 . HLA match , related donor able donate 2 . Autologous haematopoietic stem cell transplant &lt; 3 month prior enrolment 3 . Pregnancy breastfeed 4 . Uncontrolled bacterial , viral fungal infection ( currently take medication evidence progression clinical symptom radiological finding ) , inclusion patient uncontrolled viral fungal infection agree TMG 5 . Serious psychiatric psychological disorder 6 . Absence inability provide inform consent 7 . Severe comorbidity ( HCTCI comorbidity score 3 ) disease prevents treatment chemotherapy , unless otherwise agree TMG 8 . Positive antidonor HLA antibody 9 . Unable receive 2Gy TBI ( RIC pathway ) 12Gy TBI ( MAC pathway ) 10 . Patients graft rejection follow previous allograft either adult cord blood donor Donor Exclusion Criteria 1 . Positive antidonor HLA antibody recipient 2 . Pregnancy recent birth ( within 6 month prior donate cell )</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Haploidentical transplant</keyword>
	<keyword>Haematological malignancy</keyword>
	<keyword>Myeloablative</keyword>
	<keyword>Reduced intensity</keyword>
</DOC>